Infection Classification
Cross-source consensus on Infection Classification from 1 sources and 5 claims.
1 sources · 5 claims
Other
Other
Highlighted claims
- CLARITY captures microbiologically defined infections, clinically defined infections, and fever of unknown origin as infection subtypes. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Late infections are defined as infections occurring more than 365 days after CAR-T infusion. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Infections are classified using international consensus guidelines for immunocompromised hosts. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- The study collects targeted data for cytomegalovirus, COVID-19, and invasive fungal infections. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol
- Infection-related morbidity and mortality are captured through severity grading, cause of death adjudication, timing relative to therapy, and all-cause mortality. — Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol